Tag: Precision Medicine
-
Researchers Unveil a Powerful New Gene-Switch Tool
A Breakthrough in Gene Regulation Researchers at Weill Cornell Medicine have introduced a versatile, non-toxic technology that can control the activity of any gene in a cell. Dubbed a “gene-switch” tool, this innovation promises to give scientists a reliable way to turn on or turn off a target gene, enabling deeper exploration of gene function,…
-
Newborn Genomic Sequencing Could Detect Hundreds of Diseases Early
Genomic Sequencing for Newborns: A Potential Leap in Early Diagnosis Australian scientists and clinicians are championing a bold new approach to newborn health: incorporating genomic sequencing into standard newborn screening. Proponents argue that sequencing a baby’s genome at birth could reveal vulnerability to hundreds of conditions long before symptoms appear, enabling earlier interventions and improved…
-
Genomic Sequencing in Newborn Screening: Early Detection for Hundreds of Diseases
Understanding the Proposal: Genomic Sequencing for Newborns Australian scientists and doctors are proposing a bold expansion of newborn screening: add genomic sequencing to the standard tests given to all newborns. The goal is to identify a person’s vulnerability to hundreds of diseases soon after birth, enabling preventive care, timely interventions, and more personalized health trajectories…
-
New Personalized Therapy Boosts Tamoxifen Effectiveness in Breast Cancer Patients
Overview Breast cancer remains the most common cancer among women worldwide. Recent advances from the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) introduce a new personalized therapy, TAMENDOX, designed to tailor hormone treatment to individual patients. The goal is to improve the effectiveness of tamoxifen, a long-standing drug used to treat hormone-dependent breast cancer,…
-
Study Identifies New Approach to Protect the Brain During Radiation Therapy
Overview: A New Strategy to Shield the Brain During Radiation Cancer survivors often face cognitive challenges after treatment. In brain cancer, cranial radiation therapy is a standard lifesaving intervention, but it can cause lasting problems with memory, attention, and executive function. A recent experimental study from the University of California, Irvine, led by Munjal Acharya,…
-
New Brain-Sparing Approach in Radiation Therapy Could Protect Cancer Survivors’ Cognition
Groundbreaking step toward protecting the brain during radiation therapy Radiation therapy remains a cornerstone in treating brain cancers, but its cognitive side effects can shadow the relief of cancer remission. Up to 70% of survivors report challenges with memory, attention, and executive function, profoundly affecting daily life and independence. A new study from UC Irvine…
-
New approach protects the brain from radiation-induced cognitive decline
New research offers a targeted safeguard for brain cancer patients undergoing radiation therapy For many cancer survivors, the battle isn’t over once tumors are treated. Cognitive challenges—trouble with memory, attention, and concentration—can persist after cranial radiation therapy. In brain cancer patients, up to 70% report some form of cognitive impairment, a burden that affects independence…
-
CancerVax Precision Therapy Shows Promise in Reducing Liver Toxicity
Overview: A New Approach to Universal Cancer Therapy CancerVax, Inc. has announced promising in-vitro findings for its universal cancer treatment platform, a pioneering approach that leverages the body’s immune system to target and kill cancer cells. The company reports that its nanotechnology-based therapy dramatically reduces liver toxicity, a major hurdle for many cancer drugs, by…
-
CancerVax Precision Therapy Demonstrates Liver-Sparing Potential in In-Vitro Tests
Breakthrough in Precision Cancer Therapy: Liver-Sparing in Early Studies Lehi, Utah — CancerVax, Inc., a pre-clinical biotechnology company, announced today that recent in-vitro studies demonstrate a significant reduction in liver toxicity for its universal cancer treatment platform. The findings address a long-standing challenge in oncology: protecting healthy liver tissue while delivering effective cancer-killing therapy. If…
-
CancerVax Precision Therapy Delivers Safer Cancer Treatment with Liver-Sparing Promise
Introduction: A Breakthrough in Universal Cancer Therapy CancerVax, Inc. announces a promising advance in its universal cancer treatment platform, designed to harness the body’s immune system to attack cancer cells with unprecedented precision. In vitro studies indicate that this approach dramatically reduces liver toxicity, a long-standing obstacle in cancer drug development. By combining a two-step…